CG Oncology (CGON) Institutional Ownership → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free CGON Stock Alerts $25.84 -2.66 (-9.33%) (As of 05/13/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for CG Oncology (NASDAQ:CGON)CurrentInstitutional OwnershipPercentage26.56%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$363.79MNumber ofInstitutional Sellers(last 12 months)0 Get CGON Insider Trade Alerts Want to know when executives and insiders are buying or selling CG Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CGON Institutional Buying and Selling by Quarter Ad InvestorPlaceCrypto Millionaire Says: “Buy This $11 AI Coin.”Right now, you can harness the power of two bull markets... Artificial intelligence...And cryptos.Find out more about this $11 AI Coin right now CG Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2024StemPoint Capital LP40,723$1.79M0.5%N/A0.061% 5/14/2024Decheng Capital LLC5,458,810$239.64M32.1%N/A8.191% 5/14/2024 American International Group Inc.306,226$13.44M0.0%N/A0.460% 5/13/2024 Ameritas Investment Partners Inc.2,320$102K0.0%N/A0.003% 5/10/2024 Vanguard Group Inc.2,225,018$97.68M0.0%N/A3.339% 5/7/2024 TimesSquare Capital Management LLC224,073$9.84M0.1%N/A0.336% 5/1/2024 Capstone Investment Advisors LLC18,354$806K0.0%N/A0.028% 5/1/2024 BNP Paribas Financial Markets11,198$492K0.0%N/A0.017% (Data available from 1/1/2016 forward) CGON Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CGON shares? During the previous two years, the following institutional investors and hedge funds held shares of CG Oncology shares: Decheng Capital LLC ($239.64M), Vanguard Group Inc. ($97.68M), American International Group Inc. ($13.44M), TimesSquare Capital Management LLC ($9.84M), StemPoint Capital LP ($1.79M), Capstone Investment Advisors LLC ($806K), and BNP Paribas Financial Markets ($492K).Learn more on CGON's institutional investors. What percentage of CG Oncology stock is owned by institutional investors? 26.56% of CG Oncology stock is owned by institutional investors. Learn more on CGON's institutional investor holdings. Which institutional investors have been buying CG Oncology stock? The following institutional investors have purchased CG Oncology stock in the last 24 months: Decheng Capital LLC ($5.46M), Vanguard Group Inc. ($2.23M), American International Group Inc. ($306.23K), TimesSquare Capital Management LLC ($224.07K), StemPoint Capital LP ($40.72K), Capstone Investment Advisors LLC ($18.35K), and BNP Paribas Financial Markets ($11.20K). How much institutional buying is happening at CG Oncology? Institutional investors have bought a total of 8,286,722 shares in the last 24 months. This purchase volume represents approximately $363.79M in transactions. Related Companies: Arcellx Institutional Ownership Immunocore Institutional Ownership Denali Therapeutics Institutional Ownership Vericel Institutional Ownership Kymera Therapeutics Institutional Ownership Apogee Therapeutics Institutional Ownership Sana Biotechnology Institutional Ownership SpringWorks Therapeutics Institutional Ownership Recursion Pharmaceuticals Institutional Ownership Iovance Biotherapeutics Institutional Ownership This page (NASDAQ:CGON) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable ProsperityNot Trump. Not Biden. But ___________.The Freeport SocietyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressGold ManiaStansberry ResearchThe only AI company you should be looking atBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CG Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.